Dublin, Jan. 09, 2019 (GLOBE NEWSWIRE) -- The "Global Phacoemulsification Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The phacoemulsification devices market will register a CAGR of close to 4% by 2023. Glaucoma surgery combined with cataract surgery via phacoemulsification to gain traction in the market. Concomitant phacoemulsification and glaucoma surgery are together a viable treatment option for patients with both cataract and glaucoma. The minimally invasive glaucoma procedure combined with phacoemulsification results is faster visual rehabilitation and lowers the chances of intraocular pressure (IOP) spikes. Market Overview Technological advances in phacoemulsification Many advances are taking place in cataract surgery. With the improvement in cataract surgeries, the results over the past few years has resulted in a positive impact. The most important change was marked by the introduction of phacoemulsification. Lack of awareness and shortage of trained surgeons There is a distinct lack of awareness about the importance of eye care across the globe, especially in emerging economies. Factors such as lack of skilled ophthalmologists and consumer knowledge about eye care limit the patient's accessibility to eye care in emerging markets. Competitive Landscape The market appears to be fragmented and with the presence of several companies including Novartis and PhysIOL, the competitive environment is quite intense. Factors such as the glaucoma surgery combined with cataract surgery via phacoemulsification and the technological advances in phacoemulsification, will provide considerable growth opportunities to phacoemulsification devices manufactures. Bausch Health, Carl Zeiss Meditec, Johnson & Johnson, NIDEK, Novartis, and PhysIOL are some of the major companies covered in this report. Key Topics Covered: PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- Phacoemulsification consumables
- Phacoemulsification systems
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
- Glaucoma surgery combined with cataract surgery via phacoemulsification
- Increasing popularity of femtosecond laser as an alternative to phacoemulsification
- Increasing medical tourism for low-cost cataract surgery
PART 10: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 11: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bausch Health
- Carl Zeiss Meditec
- Johnson & Johnson
- NIDEK
- Novartis
- PhysIOL
For more information about this report visit https://www.researchandmarkets.com/research/s...lobal?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Optical
